<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364331">
  <stage>Registered</stage>
  <submitdate>5/09/2013</submitdate>
  <approvaldate>2/05/2014</approvaldate>
  <actrnumber>ACTRN12614000458639</actrnumber>
  <trial_identification>
    <studytitle>Evaluation of the use of Optiflow (Trade Mark) as a standard of care for oxygen delivery in critically ill patients in high acuity areas</studytitle>
    <scientifictitle>To demonstrate what Optiflow (Trademark)  as a standard of care for oxygen delivery has on clinical outcomes in high acuity patients in a combined unit (ICU/CCU/HDU) </scientifictitle>
    <utrn>U1111-1143-6310  </utrn>
    <trialacronym />
    <secondaryid>'Nil'</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Patients in High Acuity Areas</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Health service research</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>To demonstrate that when Optiflow is introduced as the standard of care for oxygen delivery in a combined unit (ICU/CCU/HDU) superior outcomes shall be achieved. 

Optiflow delivers a wide range of oxygen percentages and flows. Optiflow is a medical device. Optiflow is a nasal cannula device and will be utilised for the duration of the patient's ICU/CCU/HDU stay</interventions>
    <comparator>One site only Tauranga Hospital New Zealand
Optiflow vs Standard Care - The default for standard care will be the use of optiflow for the delivery of oxygen.
Historical Standard of care was oxygen delivered via nasal cannulae or face mask. 
Historical data collected from patients notes, admitted to the ICU/HDU/CCU from 20 May to 20 November 2012.</comparator>
    <control>Historical</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Requirement for escalation of care  Invasive ventialtion or Noninvasive ventilation within 24 hours</outcome>
      <timepoint>24 Hours</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>ICU/HDU/CCU Length of stay in hours </outcome>
      <timepoint>At ICU/HDU/CCU Discharge</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>In-hospital mortality and or morbidity during this hospital admission as recorded in medical notes by clinical assessment by attending specialist
</outcome>
      <timepoint>During this hospital admission</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cost benefit Analysis</outcome>
      <timepoint>1 Year</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients admitted to the ICU/HDU/CCU will be eligible for enrolment (convenience sampling) and there will be no withdrawals.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Exclusion will only occur if there is a known contraindication to Optiflow (e.g. as per device specification)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Other</assignment>
    <designfeatures>Historical control</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>1. Descriptive data: Means or medians with Standard Deviation
2. Ordinal data: N or %, with comparisons of ordinal data by X2
3. Continuous data: Mann-Whitney test
4. Sample size was based on historical control Convenience sample)</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>20/05/2013</anticipatedstartdate>
    <actualstartdate>20/05/2013</actualstartdate>
    <anticipatedenddate>25/12/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>500</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Tauranga Hospital, Bayof Plenty District Health Board</primarysponsorname>
    <primarysponsoraddress>Cameron Road, Tauranga, New Zealand,  3110</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Fisher &amp; Paykel Healthcare NZ
</fundingname>
      <fundingaddress>15 Maurice Paykel Place
East Tamaki
Auckland 2013
New Zealand</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The efficacy of introducing Optiflow as standard of care needs to be established in a robust way. It is proposed that a clinical reference centre will be established at the ICU/HDU/CCU at Tauranga Hospital (BOP DHB) where Optiflow will be introduced as the standard of care, therefore replacing all other oxygen delivery devices in use within the ICU, excluding NIV and INV devices. Tauranga Hospital is a secondary hospital that provides medical, surgical, paediatric, obstetric, gynaecology and mental health services to the population of the Western Bay of Plenty.  </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Bay of Plenty District Health Board Research Unit</ethicname>
      <ethicaddress />
      <ethicapprovaldate>18/04/2013</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>17/04/2013</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Health and Disablity Ethics Committee</ethicname>
      <ethicaddress>Health and Disability Ethics Committees
1 the Terrace
PO Box 5013
Wellington   6145</ethicaddress>
      <ethicapprovaldate>18/04/2013</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>17/04/2013</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Troy Browne</name>
      <address>Director of ICU/HDU
Tauranga Hospital
Cameron Road
Tauranga
New Zealand 3112</address>
      <phone>+64 7 5798710</phone>
      <fax />
      <email>troy.browne@bopdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Jennifer Goodson</name>
      <address>Tauranga Hospital
Cameron Road
Tauranga
New Zealand 3112</address>
      <phone>+64 7 5798710</phone>
      <fax />
      <email>jennifer.goodson@bopdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Troy Browne</name>
      <address>Director of ICU/HDU
Tauranga Hospital
Cameron Road
Tauranga
New Zealand 3112</address>
      <phone>+ 64 7 5798710</phone>
      <fax />
      <email>troy.browne@bopdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>